Novel Aspects of the regulation of intestinal lipoprotein particle secretion in humans

人体肠道脂蛋白颗粒分泌调节的新方面

• 批准号: 354563
• 负责人: Lewis Gary F
• 金额: $ 80.25万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=354563&lang=en
• 关键词: Apolipoprotein; Diabetes; Insulin Resistance; Intestine; Lipoprotein; Liver

The fourth quarter of the 20th century heralded the onset of a worldwide epidemic of obesity, metabolic syndrome and type 2 diabetes. These conditions are associated with a cluster of blood fat (lipid and lipoprotein) abnormalities, the presence of which

世纪的第四季度预示着肥胖、代谢综合征和2型糖尿病在全球范围内流行的开始。 这些疾病与一系列血脂（脂质和脂蛋白）异常有关，